Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02826655 · ClinicalTrials.gov registry record · NA

Adaptive Optics for Ophthalmic Technologies

A NA study, sponsored by Duke University.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT02826655 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 4 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02826655, a NA study, was terminated before completion, sponsored by Duke University.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

This is a feasibility study to assess the use of wide field adaptive optics optical coherence tomography (WF-AO-OCT) to determine whether there are structural differences in the peripheral retina in participants diagnosed with diabetic retinopathy compared to a healthy control group. This study being conducted under an abbreviated IDE. The investigators will analyze data using descriptive statistics. Risks related to light exposure will be managed by ensuring that the exposure to the WF-AO-OCT light source is well below maximum permissible limits for safe exposure.

Interventions

  • DEVICE WF-AO-OCT

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2016-06
Est. Completion 2016-06
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT02826655

The ClinicalTrials.gov registry entry for NCT02826655 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which WF-AO-OCT is the first listed.

NCT02826655 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02826655 about?

NCT02826655 is a clinical study titled "Adaptive Optics for Ophthalmic Technologies". This is a feasibility study to assess the use of wide field adaptive optics optical coherence tomography (WF-AO-OCT) to determine whether there are structural differences in the peripheral retina in participants diagnosed with diabetic retinopathy compared to a healthy control group. This study bein...

What is the current status of trial NCT02826655?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2016-06. Estimated completion is 2016-06.

What interventions are being tested in trial NCT02826655?

The interventions under investigation include: WF-AO-OCT (DEVICE).

Who is sponsoring clinical trial NCT02826655?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.